Rhumbline Advisers Buys 4,621 Shares of Viridian Therapeutics, Inc. (NASDAQ:VRDN)
Rhumbline Advisers lifted its stake in shares of Viridian Therapeutics, Inc. (NASDAQ:VRDN – Free Report) by 4.6% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 104,559 shares of the company’s stock after acquiring an additional 4,621 shares during the quarter. Rhumbline Advisers’ […]
Rhumbline Advisers lifted its stake in shares of Viridian Therapeutics, Inc. (NASDAQ:VRDN – Free Report) by 4.6% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 104,559 shares of the company’s stock after acquiring an additional 4,621 shares during the quarter. Rhumbline Advisers’ […]
